https://bpno.dk/medtalks/patient-reported-outcomes-of-belzutifan-versus-everolimus-in-patients-with-previously-treated-advanced-renal-cell-carcinoma/
Patient-Reported Outcomes of Belzutifan versus Everolimus in Patients with Previously Treated...
Aug 8, 2024 - In this MEDtalk, Dr. Thomas Powles discusses the quality of life data from the LITESPARK-005 study, a randomised phase III study comparing belzutifan with...
patient reported outcomesin patientsbelzutifanversuseverolimus
https://medischeoncologiegroningen.nl/artikelen/belzutifan/
Belzutifan - Medische Oncologie Groningen
Oct 24, 2025 - Behandeling met Belzutifan gaat via Early Access Programma, dit betreft geen standaardbehandeling. Overleg altijd eerst met dr. Nuver (j.nuver@umcg.nl / intern...
belzutifanoncologiegroningen
https://www.cancernetwork.com/view/lenvatinib-belzutifan-exhibits-durable-antitumor-activity-safety-in-ccrcc
Lenvatinib/Belzutifan Exhibits Durable Antitumor Activity/Safety in ccRCC | CancerNetwork
May 21, 2026 - Greater responses were observed in a cohort of patients with renal cell carcinoma receiving lenvatinib plus belzutifan vs pembrolizumab plus lenvatinib.
belzutifanexhibitsdurableactivitysafety